Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea

Objectives: Plasma-based comprehensive circulating cell-free DNA (cfDNA) next generation sequencing (NGS) has shown utility in advanced non-small cell lung cancer (aNSCLC). The aim of this study was to determine the feasibility of cfDNA-based NGS to identify actionable gene alterations in patients w...

Full description

Bibliographic Details
Main Authors:	Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Suyog Jain, Steve Olsen, Byoung Chul Cho
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Cancer Treatment and Research Communications
Subjects:	Non-small cell lung cancer NSCLC Circulating cell-free tumor DNA Next generation sequencing
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468294223000369

Similar Items

Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
by: Jiyun Lee, et al.
Published: (2024-04-01)

Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
by: Yen-Han Tseng, et al.
Published: (2024-01-01)

Circulating cell-free nucleic acids of plasma in human aging, healthy aging and longevity: current state of knowledge
by: Nicolas P. Tessier, et al.
Published: (2023-11-01)

Enhancing mutation detection in multiple myeloma with an error-corrected ultra-sensitive NGS assay without plasma cell enrichment
by: Jin Ju Kim, et al.
Published: (2024-08-01)

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
by: Byoung Chul Cho, et al.
Published: (2022-03-01)

Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer
by: Nada Ezzeldin, et al.
Published: (2024-06-01)

Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer
by: Vahid Yaghoubi Naei, et al.
Published: (2024-01-01)

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
by: Aleksandra Bożyk, et al.
Published: (2022-10-01)

Utilizing Cell-Free Urinary and Plasma Tumor DNA to Predict Pathologic Stage at Radical Cystectomy
by: Prithvi B. Murthy, et al.
Published: (2023-07-01)

Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study
by: Andrew Condappa, et al.
Published: (2020-09-01)

Quantitative analysis of plasma DNA in anal cancer patients
by: Ewa Małusecka, et al.
Published: (2022-06-01)

Detection of mutations in plasma cell-free DNA of colorectal cancer patients and comparison with cancer panel data for tissue samples of the same cancers
by: Suji Min, et al.
Published: (2019-11-01)

Cell-free DNA next-generation sequencing for Mycobacterium tuberculosis obtained from plasma of children with active tuberculosis
by: Shuting Quan, et al.
Published: (2025-03-01)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)
by: Dong Ki Lee, et al.
Published: (2024-12-01)

Liquid biopsy: paving a new avenue for cancer research
by: Keerthi Kurma, et al.
Published: (2024-12-01)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
by: Yidong Zhou, et al.
Published: (2019-05-01)

Genetic detection of congenital heart disease
by: Sumathi I. Rachamadugu, et al.
Published: (2022-09-01)

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Pablo J. Dopico, et al.
Published: (2022-03-01)

Comparative Analysis of Free-Circulating and Vesicle-Associated Plasma microRNAs of Healthy Controls and Early-Stage Lung Cancer Patients
by: Luigi Pasini, et al.
Published: (2022-09-01)

Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients
by: Hyun Soo Song, et al.
Published: (2021-12-01)

Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
by: Jieun Lee, et al.
Published: (2017-03-01)

Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer
by: Wei-Wei Peng, et al.
Published: (2023-09-01)

Microsatellite Instability in Colorectal Cancer Liquid Biopsy—Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker
by: Francis Yew Fu Tieng, et al.
Published: (2021-03-01)

Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases
by: Xiaocui Liu, et al.
Published: (2024-01-01)

Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report
by: Sangho Nam, MD, et al.
Published: (2024-02-01)

Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson’s disease and multiple system atrophy
by: Chao Ying, et al.
Published: (2024-12-01)

Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients
by: Mouadh Barbirou, et al.
Published: (2022-02-01)

Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer
by: Karolina Buszka, et al.
Published: (2022-09-01)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
by: Yidan Ma, et al.
Published: (2024-09-01)

A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer
by: Chamindi Seneviratne, et al.
Published: (2022-11-01)

Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy
by: Simiao Qiao, et al.
Published: (2023-03-01)

Ultrashort Cell-Free DNA Fragments and Vimentin-Positive Circulating Tumor Cells for Predicting Early Recurrence in Patients with Biliary Tract Cancer
by: Sung Hee Park, et al.
Published: (2024-11-01)

Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
by: Florent Mouliere, et al.
Published: (2021-07-01)

Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma
by: Shuchan Li, et al.
Published: (2023-03-01)

Liquid Biopsy Profiling with Multiple Tests in Patients with Metastatic Breast Cancer
by: Nikki Higa, et al.
Published: (2024-05-01)

Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> System
by: Gabrielle Wishart, et al.
Published: (2024-01-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues
by: Qikang Hu, et al.
Published: (2023-12-01)

Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H<sub>2</sub>AX, CHK2 and p53
by: Ji-Hyun Kim, et al.
Published: (2022-04-01)

Prognostic implications of PD-L1 expression in patients with angiosarcoma
by: Jii Bum Lee, et al.
Published: (2021-06-01)